The status of tuberculosis vaccine development
LK Schrager, J Vekemens, N Drager… - The Lancet Infectious …, 2020 - thelancet.com
Tuberculosis represents the leading global cause of death from an infectious agent.
Controlling the tuberculosis epidemic thus represents an urgent global public health priority …
Controlling the tuberculosis epidemic thus represents an urgent global public health priority …
Tuberculosis vaccine: A journey from BCG to present
Tuberculosis (TB) is the leading cause of death worldwide due to an infectious disease,
causing around 1.6 million deaths each year. This situation has become more complicated …
causing around 1.6 million deaths each year. This situation has become more complicated …
The current status, challenges, and future developments of new tuberculosis vaccines
W Gong, Y Liang, X Wu - Human vaccines & immunotherapeutics, 2018 - Taylor & Francis
Mycobacterium tuberculosis complex causes tuberculosis (TB), one of the top 10 causes of
death worldwide. TB results in more fatalities than multi-drug resistant (MDR) HIV strain …
death worldwide. TB results in more fatalities than multi-drug resistant (MDR) HIV strain …
[HTML][HTML] Miliary tuberculosis: A new look at an old foe
SK Sharma, A Mohan, A Sharma - Journal of Clinical Tuberculosis and …, 2016 - Elsevier
Miliary tuberculosis (TB), is a fatal form of disseminated TB characterized by tiny tubercles
evident on gross pathology similar to innumerable millet seeds in size and appearance …
evident on gross pathology similar to innumerable millet seeds in size and appearance …
Drug-resistant TB: deadly, costly and in need of a vaccine
J Manjelievskaia, D Erck, S Piracha… - Transactions of the …, 2016 - academic.oup.com
TB is an underappreciated public health threat in developed nations. In 2014, an estimated
9.6 million TB cases and 1.5 million deaths occurred worldwide; 3.3% of these cases …
9.6 million TB cases and 1.5 million deaths occurred worldwide; 3.3% of these cases …
A Structural View at Vaccine Development against M. tuberculosis
M Romano, F Squeglia, E Kramarska, G Barra… - Cells, 2023 - mdpi.com
Tuberculosis (TB) is still the leading global cause of death from an infectious bacterial agent.
Limiting tuberculosis epidemic spread is therefore an urgent global public health priority. As …
Limiting tuberculosis epidemic spread is therefore an urgent global public health priority. As …
Multi-stage subunit vaccines against Mycobacterium tuberculosis: an alternative to the BCG vaccine or a BCG-prime boost?
Introduction: More than two billion people are latently infected with Mycobacterium
tuberculosis. Most tuberculosis (TB)-subunit vaccines currently in various stages of clinical …
tuberculosis. Most tuberculosis (TB)-subunit vaccines currently in various stages of clinical …
Efficacy of Mycobacterium vaccae immunotherapy for patients with tuberculosis: a systematic review and meta-analysis
CY Huang, WY Hsieh - Human vaccines & immunotherapeutics, 2017 - Taylor & Francis
Tuberculosis (TB) is a significant cause of illness and death worldwide. Immunotherapy has
been investigated in the treatment of TB. The purpose of this study was to perform a meta …
been investigated in the treatment of TB. The purpose of this study was to perform a meta …
Mycobacterium tuberculosis lipoproteins in virulence and immunity – fighting with a double‐edged sword
Bacterial lipoproteins are secreted membrane‐anchored proteins characterized by a lipobox
motif. This lipobox motif directs post‐translational modifications at the conserved cysteine …
motif. This lipobox motif directs post‐translational modifications at the conserved cysteine …
A century of attempts to develop an effective tuberculosis vaccine: Why they failed?
Tuberculosis (TB) remains a major global health problem despite widespread use of the
Bacillus BCG vaccine. This situation is worsened by co-infection with HIV, and the …
Bacillus BCG vaccine. This situation is worsened by co-infection with HIV, and the …